News


September 2014

Index Ventures, Advent Life Sciences and Gilde Healthcare invest £10 million Series A financing to develop LEVI-04 to proof-of-concept first-in-human clinical trials

May 2014

Simon Westbrook, CEO presents at Biotrinity 2014

April 2014

Innovate UK awards £2.4 million grant

February 2014

PAINCAGE Consortium (SCUOLA NORMALE SUPERIORE ITALY; EUROPEAN BRAIN RESEARCH INSTITUTE RITA LEVI MONTALCINI FONDAZIONE EBRI (EBRI) ITALY: AARHUS UNIVERSITET DENMARK; The Medical University of Vienna Austria; LEVICEPT LTD, UK; KINGS COLLEGE LONDON, UK; UNIVERSITAD DE SALAMANCA Spain; GENOMNIA S.r.l ITALY; INSTITUT NATIONAL DE LA SANTE’ ET DE LA RECHERCHE MEDICALE (INSERM), France) have been awarded €5.9M:

The title of the project: The NGF system and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain

September 2013

Simon Westbrook acquires asset from Pfizer Ltd

March 2012

Index Ventures awards seed funding